广东证监局决定，责令ST福能改正，给予警告，并处以650万元罚款。此外，广东证监局同日对相关责 任人员下发《行政处罚决定书》，相关责任人员不属于公司现任董事、高级管理人员。 ST福能表示，公司本次收到的《行政处罚决定书》中认定的情况与《行政处罚事先告知书》一致，涉 及的是公司原子公司大宇精雕违法违规事项。公司判断上述《行政处罚决定书》涉及的违法违规行为未 触及重大违法强制退市的情形。截至公告日，公司各项生产经营活动正常有序开展。 （文章来源：北京商报） 北京商报讯2月6日晚间，ST福能（300173）披露公告称，公司收到广东证监局下发的《行政处罚决定 书》。 《行政处罚决定书》显示，经查明，ST福能信息披露违法违规的事实包括，2020年6月，ST福能子公司 深圳大宇精雕科技有限公司（以下简称"大宇精雕"）与重庆市中光电显示技术有限公司（以下简称"重 庆中光电"）约定，先由重庆中光电向大宇精雕支付虚假货款，大宇精雕确认虚假应收款，大宇精雕再 以虚构采购业务、支付预付款的形式，最终将资金转回重庆中光电。大宇精雕通过上述方式少确认应收 款的减值损失、虚增预付款，2020年虚增利润约3579.85万元，占ST福能20 ...

Core Viewpoint - The company Beilingsong (688793.SH) disclosed that its actual controller, Ma Xuejun, received a notice of investigation from the China Securities Regulatory Commission (CSRC) for suspected market manipulation, which is not expected to significantly impact the company's daily operations [1][2]. Group 1: Investigation and Regulatory Actions - On February 4, 2026, Beilingsong received a notice from the CSRC regarding Ma Xuejun's investigation for suspected market manipulation [1]. - Previously, on December 25, 2025, the company and Ma Xuejun were also notified by the CSRC for suspected violations of information disclosure laws [2]. Group 2: Shareholding Structure - As of November 20, 2025, the major shareholders of Beilingsong include Ma Xuejun with a 37.51% stake, followed by Ningbo Heting Investment Co., Ltd. with 7.49%, and Wang Naiqing with 5.6% [3]. - The sixth largest shareholder is China Bank Co., Ltd. - Baoying Core Advantage Flexible Allocation Mixed Securities Investment Fund, holding 1.98% [2][3]. Group 3: Financial Information - Beilingsong raised a total of 422 million yuan during its IPO, with a net amount of 359 million yuan after deducting issuance costs, which was 138 million yuan less than the originally planned net fundraising amount [4]. - The company initially intended to raise 497 million yuan for projects including marketing network construction, R&D center upgrades, and operational capital [4]. Group 4: Company Background - Beilingsong, established in 2000 and located in Shenzhen, Guangdong Province, primarily engages in the rubber and plastic products industry, with a registered capital of approximately 859.45 million yuan [5].

Core Viewpoint - The recent developments regarding Weichuang Co., Ltd. (威创股份) indicate significant legal and regulatory challenges due to false statements and information disclosure violations, leading to investor compensation claims and potential further legal actions. Group 1: Legal Developments - On February 3, 2026, Weichuang announced a major lawsuit ruling, where the company was ordered to compensate an investor a total of 116,550.88 yuan for investment losses, commissions, and stamp duties, with certain individuals held jointly liable for this debt [1][4]. - The law firm representing the investors, led by attorney Xu Feng, noted that this ruling signifies a first-instance victory for investors, and those meeting specific criteria may continue to file lawsuits [1][4]. Group 2: Regulatory Violations - On February 21, 2025, Weichuang received an administrative penalty decision from the Guangdong Regulatory Bureau of the China Securities Regulatory Commission, revealing multiple violations of information disclosure regulations [2][5]. - Specific violations included failure to disclose changes in actual control, late reporting of acquisition agreements, and false records in the 2023 semi-annual and third-quarter reports regarding non-operating fund occupations and transactions with related parties [2][3][5]. Group 3: Investor Compensation Opportunities - Investors who purchased Weichuang shares between June 21, 2023, and December 23, 2023, and sold or held the shares after December 23, 2023, are eligible to initiate compensation claims [3][5].

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我 一、实控人被立案调查 2月5日，倍轻松（维权）发布公告称，公司于2月4日收到证监会对实际控制人马学军下发的《立案告知 书》，因其涉嫌操纵证券市场，证监会决定对其立案。 倍轻松表示，本次调查事项系对马学军个人的调查，不会对公司的日常运营造成重大影响，其本人仍在 公司正常履职。目前公司各项经营活动和业务均正常开展。 此外该公司还被立案调查中，倍轻松于12月25日晚发布公告称公司及实际控制人因涉嫌信息披露违法违 规，被中国证监会立案调查。根据历史案例，上市公司一旦被证监会立案调查，最终被认定为信息披露 违法违规并受到处罚的可能性较大。 二、投资者维权要求 梳理过往公告发现，2025年8月2日，公司就曾自查发现实控人在以往年度存在通过员工借款、提前支付 供应商采购款等方式占用公司资金的行为。立案调查或与实控人不断侵占上市公司资金有关。 信息披露义务人在证券交易 ...

登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 关注@新浪证券、微信关注新浪券商基金、百度搜索新浪股民维权、访问新浪财经客户端、 新浪财经首页都能找到我 一、业绩预计大幅增长 登录新浪财经APP 搜索【信披】查看更多考评等级 受损股民可至新浪股民维权平台登记该公司维权：http://wq.finance.sina.com.cn/ 1月27日晚，臻镭科技（维权）发布2025年业绩预增公告。公告显示，公司预计2025年实现归母净利润 1.23亿元至1.45亿元，同比增长529.64%至642.26%。 业绩虽然向好，但是其背后仍面临着投资者的索赔，2025年12月26日，臻镭科技发布公告，收到中国证 监会下发的《立案告知书》。因公司涉嫌信息披露违法违规，根据相关法律法规，中国证监会决定对该 公司进行立案。 上海沪紫律师事务所刘鹏律师符合于2025年12月26日（含当日）之前买入，并在2025年12月27日之后卖 出或仍持有而亏损即可加入索赔。（臻镭科技维权入口） 二、相关财报存在问题 在收到《立案告知书》的 ...

Core Viewpoint - The company, Beilingsong (688793), is under investigation by the China Securities Regulatory Commission (CSRC) for alleged market manipulation by its actual controller, Ma Xuejun, which may impact investor confidence and market perception of the company [2][4]. Group 1: Investigation Details - On February 4, the company received a notice from the CSRC regarding the investigation of Ma Xuejun for suspected market manipulation [2]. - The investigation pertains solely to Ma Xuejun as an individual and is not expected to significantly affect the company's daily operations, with Ma continuing to fulfill his duties [4]. Group 2: Company Background - Beilingsong is a national high-tech enterprise that focuses on the innovation, research, and development of health products, primarily engaged in the design, production, and sales of smart portable massagers [4]. - The company went public on the Sci-Tech Innovation Board in 2021 [4]. Group 3: Financial Performance - The company anticipates a net loss for the fiscal year 2025, projecting a net profit attributable to shareholders of between -1.05 billion to -840 million [4]. - The expected net profit after deducting non-recurring gains and losses is projected to be between -920 million to -710 million [4]. - The decline in revenue and profit is attributed to strategic adjustments in response to industry trends and market conditions, alongside increased fixed costs and ineffective sales expense management [5].

Core Viewpoint - The company, Beiliang, is under investigation by the China Securities Regulatory Commission (CSRC) for alleged market manipulation involving its actual controller, Ma Xuejun, which may impact investor confidence and future operations [1][5]. Group 1: Investigation Details - On February 4, the CSRC issued a notice to Ma Xuejun regarding the investigation for suspected market manipulation [1]. - This investigation is separate from a previous case in December 2022, where both the company and Ma Xuejun were investigated for information disclosure violations [5]. Group 2: Company Operations - Beiliang stated that the investigation pertains to Ma Xuejun personally and will not significantly affect the company's daily operations, with him continuing to fulfill his duties [3][4]. - The company is committed to complying with legal and regulatory requirements and will keep stakeholders informed about the investigation's progress [4]. Group 3: Financial Performance - Beiliang is a high-tech enterprise focused on the innovation and development of health products, primarily engaged in the design, research, production, sales, and service of smart portable health hardware [7]. - The latest earnings forecast indicates that the company expects to report a net loss of between 84 million to 105 million yuan for 2025, marking a shift from profit to loss [7]. - As of February 5, Beiliang's stock closed at 22.97 yuan per share, reflecting a 0.75% increase, with a total market capitalization of 1.974 billion yuan [7].

值得一提的是，在2025年12月底马学军刚遭到证监会立案调查。倍轻松2025年12月25日晚间披露公告显示， 因公司及马学军涉嫌信息披露违法违规，证监会决定对公司及马学军立案。这也意味着，不足一个半月马学 军两度遭到证监会立案。 资料显示，马学军1971年4月出生，2001年8月至今任倍轻松董事长、总经理，全面负责公司的经营管理。 实际上，除了公司及实控人遭立案的利空消息之外，倍轻松目前也面临不少"烦恼"。 被证监会立案不足一个半月，倍轻松（688793）实控人马学军又遭到了立案。2月5日晚间，倍轻松披露公告 称，公司于2月4日收到证监会对马学军下发的《立案告知书》，因其涉嫌操纵证券市场，证监会决定对其立 案。 倍轻松表示，本次调查事项系对马学军个人的调查，不会对公司的日常运营造成重大影响，其本人仍在公司 正常履职，目前公司各项经营活动和业务均正常开展。 对于公司业绩变动的原因，倍轻松表示，公司结合行业发展趋势及市场环境变化对经营战略进行阶段性调 整，受战略调整过渡期影响，报告期内营业收入较上年同期下降，进而带动毛利额下降；同时，经营端销售 费用投入产出效能未达预期，而固定支出和刚性成本短期内无法与营收规模实 ...

2月4日，广东聚石化学股份有限公司（下称：聚石化学）发布公告称，正式收到中国证监会广东监管局 下发的《行政处罚决定书》。因涉及信息披露违法违规，公司及4名时任相关责任人合计被罚670万元。 公告显示，此次事件始于2025年11月21日，公司因涉嫌信息披露违法违规收到中国证监会下发的《立案 告知书》；2026年1月9日，公司收到广东监管局下发的《行政处罚事先告知书》，违法事实与处罚方向 初步明确。如今调查正式公布，处罚决定落地。 对陈钢给予警告，并处180万元罚款； 对刘鹏辉给予警告，并处90万元罚款； 对伍洋给予警告、处以80万元罚款； 徐建军给予警告，各处以80万元罚款。 上述4名责任人合计被罚430万元。 根据《行政处罚决定书》，聚石化学及其子公司通过三类无商业实质的虚假贸易业务，导致2023年半年 度财务报告存在虚假记载，具体包括： 其一，通过其当时实际控制的4家贸易公司进行虚假交易，虚增收入超过8655万元，虚增成本8823.81万 元，虚减利润168.72万元； 其二，介入第三方贸易链条，利用自制的货权转让单循环交易，虚增收入和成本各约5223.6万元，未对 利润产生影响； 其三，子公司销售货物但未 ...

Core Viewpoint - The company, Qianyin High-Tech, is under investigation by the China Securities Regulatory Commission (CSRC) for suspected violations of information disclosure laws, leading to potential claims from affected investors [1][4]. Financial Reporting Issues - Qianyin High-Tech announced corrections to previous accounting errors and adjustments to its financial statements for 2023 and 2024, with KPMG providing a qualified opinion on the 2024 financial report due to issues related to accounts receivable from three distilleries and another company [1][3]. - The company identified that the three distilleries faced operational difficulties due to market conditions, and one associated company had liquidity issues since 2023, prompting a reassessment of the impairment losses on receivables [2][7]. - The company plans to recognize a 20% impairment loss on the receivables from the distilleries as of the end of 2023, with a potential 100% impairment loss in 2024 if the receivables remain uncollectible [2][7]. Legal and Compensation Actions - Investors who purchased Qianyin High-Tech shares between March 23, 2024, and April 30, 2025, and sold or held them after April 30, 2025, are eligible to prepare for claims against the company [4][8]. - The law firm representing investors has also initiated claims for another company, Renzi Hang, which has faced similar legal issues, indicating a broader trend of investor compensation actions in the market [4][8].